What are the next steps for the U.S. House of Representatives investigation into a market of aborted “baby body parts” that according to all other accounts—three other congressional committees, 13 states, and a Texas grand jury—doesn’t exist?

Rep. Marsha Blackburn (R-TN), the chair of the so-called Select Investigative Panel on Infant Lives, said she had not decided on the topic of the next hearing, nor whether to subpoena the leader of the anti-choice front group fueling the investigation.

“We’ll have something that we’ll look at in September, but no decisions [yet],” Blackburn said in a July 14 interview with Rewire.

Blackburn’s remarks followed a press conference coinciding with the one-year anniversary of the first Center for Medical Progress (CMP) videos that still serve as the basis for the $1.2 million investigation.

“We’re continuing to pursue [options], we have a tremendous amount of information that has come through to us through whistleblowers and individuals, so we’ll continue to work,” she said.

Congress adjourned for a seven-week recess the day after Blackburn presented House Majority Whip Steve Scalise (R-LA) with the panel’s interim update, which repeats many of the same widely discredited allegations from CMP and other anti-choice groups cited in the document.

The panel will release a final report by the end of the year. That’s the only definitive next step in an investigation that started with allegedly falsified evidence of fetal tissue trafficking and pivoted in recent months to later abortion care, including subpoenaing a prominent provider and calling for a state-level criminal investigation of a university and abortion clinic supposedly in collusion.

Blackburn would not commit to subpoenaing David Daleiden, the CMP leader under felony indictment in Texas and the subject of lawsuits in California. Republicans’ interim update called Daleiden an “investigative journalist,” even though more than two dozen of the nation’s preeminent journalists and journalism scholars recently filed an amicus brief explaining why that isn’t so in the federal court case between CMP and the National Abortion Federation.

“I think it’s inappropriate to predetermine any decisions,” Blackburn said about the possibility of a Daleiden appearance before the panel. “We’re an investigative panel. We’re going go where the facts take us.”

The interim update indicates that the investigation will continue to focus on later abortion care. Blackburn, however, deflected questions about targeting later abortion care in her interview with Rewire.

Blackburn seemingly walked back the pledge she made at a faith-based conference last month to pursue contempt of Congress charges for “middle men” and their suppliers—“big abortion”—who she alleged have not cooperated with her subpoenas. Blackburn’s panel spokesperson previously told Rewire that the panel required the names of those involved in fetal tissue transactions and research in order to understand how things work.

Democrats have repeatedly objected to the subpoenas, escalating their concerns after Blackburn initially failed to redact researchers’ names and contact information in her call for a federal abortion inquiry.

“We’re going to pursue getting the truth and delivering a report that is factual, that is truthful, and can be utilized by the authorizing committees,” Blackburn said in response to a question about the contempt charges at the press conference.

Blackburn and her fellow Republicans had no such reservations about going after Democrats on the panel.  They accused Democrats of furnishing subpoena recipients with a memo to subvert requests for information. The final pages of the interim update includes a chart alleging the extent to which various organizations, hospitals, procurement companies, abortion providers, and others have or have not complied with the subpoenas.

Emails obtained by Rewire show a Democratic staffer refuting such accusations last month. Democrats produced their own status update for members, not a memo advising noncompliance for subpoena recipients, the staffer said in a June email to a Republican counterpart on the panel.